News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact

 

Nicklas Westerholm, CEO
[email protected]

Yilmaz Mahshid, CFO
[email protected]

 

Calendar and upcoming reports

April 30, 2025
Interim Report Q1 2025 (7:00am CEST)

May 6, 2025
Annual General Meeting

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]